Intercept Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ADORINI LUCIANO officer: See Remarks
 Restricted Stock Units 3,245 N/A N/A
Option
AKKARAJU SRINIVAS director
 Restricted Stock Units 325 N/A N/A
Option
VEITINGER KLAUS R DR director
 Restricted Stock Units 649 N/A N/A
Option
PRUZANSKI MARK director
 Restricted Stock Units 24,339 N/A N/A
Option
AKKARAJU SRINIVAS director
 Common stock 325 N/A N/A
Option
DUNCAN BARBARA GAYLE officer: Chief Accounting Officer
 Common stock 6,490 N/A N/A
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Restricted Stock Units 8,113 $10.4 $84,375
Option
WILLIAMS NICOLE director
 Restricted Stock Units 735 N/A N/A
Option
FUNDARO PAOLO director, 10 percent owner
 Restricted Stock Units 649 N/A N/A
Option
ADORINI LUCIANO officer: See Remarks
 Common stock 3,245 N/A N/A
Option
WILLIAMS NICOLE director
 Common stock 735 N/A N/A
Option
SILVERSTEIN JONATHAN director
 Restricted Stock Units 649 N/A N/A
Option
ORBIMED ADVISORS LLC director
 Common Stock, par value $0.001 per share 649 N/A N/A
Option
DUNCAN BARBARA GAYLE officer: Chief Accounting Officer
 Restricted Stock Units 6,490 N/A N/A
Option
ORBIMED ADVISORS LLC director
 Restricted Stock Units 649 N/A N/A
Option
FUNDARO PAOLO director, 10 percent owner
 Common stock 649 N/A N/A
Option
PRUZANSKI MARK director
 Common stock 24,339 N/A N/A
Option
VEITINGER KLAUS R DR director
 Common stock 649 N/A N/A
Option
SILVERSTEIN JONATHAN director
 Common stock 649 N/A N/A
Purchase
AKKARAJU SRINIVAS director
 Common Stock, par value $0.001 per share 700,000 $15 $10,500,000
Purchase
ORBIMED ADVISORS LLC director
 Common Stock, par value $0.001 per share 333,334 $15 $5,000,010
Purchase
SILVERSTEIN JONATHAN director
 Common Stock, par value $0.001 per share 333,334 $15 $5,000,010
Purchase
SILVERSTEIN JONATHAN director
 Series C Preferred Stock 10,500,000 $2 $21,000,000
Purchase
TALLARIGO LORENZO director
 Series C Preferred Stock 4,500,000 $9.31 $41,895,000
Option
SHAPIRO DAVID officer: Chief Medical Officer
 Options to Purchase Common Stock 3,750 $10.4 $39,000

Showing 850 to 875 of 875 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: